Loading clinical trials...
Loading clinical trials...
Acute myeloid leukemia (AML) is a heterogeneous group of diseases characterized by uncontrolled proliferation of the myeloid line of white blood cells and impaired production of normal blood cells. If...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
CSL Limited
NCT07500441 · Acute Myeloid Leukemia (AML)
NCT05768932 · Advanced Solid Tumor, TNBC - Triple-Negative Breast Cancer, and more
NCT05756777 · Acute Myeloid Leukemia (AML)
NCT07451912 · Acute Myeloid Leukemia (AML), CEBPA Mutation, and more
NCT06660368 · Relapsed or Refractory Acute Myeloid Leukemia (AML)
Westmead Hospital
Westmead, New South Wales
Royal Brisbane and Women's Hospital
Brisbane, Queensland
Princess Alexandra Hospital
Woolloongabba, Queensland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions